「news2024年12月」の検索結果
69件：36～40件目を表示
-
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju
https://www.senju.co.jp/english/about/philosophy.html -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject
https://www.senju.co.jp/english/about/production.html -
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50
https://www.senju.co.jp/english/about/outline.html -
Data And Statistics | About Senju | SENJU Pharmaceutical
Sales Revenue. Operating Profit and Ordinary Profit 2020.3 2021.3 2022.3* 2023.3* 2024.3* Sales Revenue 41.2 40.7 40.8 46.4 48.9 Operating Profit 2.2 5.4 6.9 7.4 7.1 Ordinary Profit 4.3 8.0 9.1 8.7 9.
https://www.senju.co.jp/english/about/sales.html